Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Follicum applies for the start of a Phase II study at the German Medicines Agency

Follicum AB ("Follicum" or "the company") today announced that the company has filed an application for the initiation of a Phase IIa clinical trial with FOL-005 on scalp to study hair growth to the German Medicines Agency, BfArM and to the Ethics Committees. The goal is to start the study after approval by the authorities early 2018.Preparations for the new clinical Phase IIa study with FOL-005 on scalp are progressing as planned, and we have now reached an important milestone in submitting the application to the authority and Ethics Committees in collaboration with the Clinical Research

SimCorp A/S – Share buyback program

On 24 August 2017 SimCorp A/S announced a share buyback program in compliance with the provisions of Regulation No. 596/2014 of the European Parliament and of the Council on market abuse (the Market Abuse Regulation - MAR) and delegated legislation under MAR. In connection with the program SimCorp A/S will repurchase shares for an amount of up to EUR 7.5m, to be executed during the period from 24 August 2017 to 31 December 2017. The following transactions have been executed under the program:     Date                 Number of shares Average Amount (DKK)

Innovative Rotating Buoyancy Modules Create Safe Buckling Zones

Trelleborg’s offshore operation recently developed a new Rotating Buoyancy Module system for buckling mitigation for subsea pipelines. The advanced solution is engineered to roll on the seabed to reduce lateral friction and berm creation thereby creating repeatable and predictable pipeline behavior. Steven Bray, Oil and Gas Business Manager with Trelleborg’s offshore operation, states: “Doing business in today’s globalized markets requires a long-term approach with solutions that protect people, the environment and our customer’s investment. We are committed to improving the

Surrogate marker and design of Calliditas Therapeutics’ IgA nephropathy Phase 3 study agreed with the FDA

Stockholm, November 20, 2017. Calliditas Therapeutics AB (formerly Pharmalink AB) announced today that the US Food & Drug Administration (FDA) has accepted its Phase 3 study design for its lead candidate Nefecon based on proteinuria as endpoint for accelerated approval. A global Phase 3 program in IgA nephropathy has been initiated, and patient enrolment is expected to start in 2018.The design for the Nefecon Phase 3 study was agreed at the latest meeting with the FDA in September 2017, building on the groundbreaking acceptance of proteinuria as a surrogate marker for accelerated approval,

Bittium exhibits products and solutions for authority and soldier communications at Milipol exhibition in Paris

Press release Free for publication on November 20, 2017 at 11.00am. (CET +1) Bittium exhibits products and solutions for authority and soldier communications at Milipol exhibition in Paris Oulu, Finland, November 20, 2017 – Bittium will exhibit its newest products and solutions for authority and soldier communications at Milipol exhibition in Paris, France November 21-24. At the event Bittium will showcase the secure and strong Bittium Tough Mobile™ 4G/LTE smartphone and the related Bittium Secure Suite™ back-end system that have received official Confidential level encryption

Detection Technology Plc - Managers' Transactions

Detection Technology Plc Managers' Transactions 20 November 2017 at 11:00 (EET) Detection Technology Plc - Managers' Transactions ____________________________________________ Person subject to the notification requirement Name: Hyvärinen, Kari Position: Other senior manager Issuer: Detection Technology Plc LEI: 743700IXKYKNXJ6BFL39 Notification type: INITIAL NOTIFICATION Reference number: 743700IXKYKNXJ6BFL39_20171118093642_2 ____________________________________________ Transaction date: 2017-11-16 Venue: FIRST NORTH FINLAND (FNFI) Instrument type:

SpiffX partner with Bede Gaming to distribute Take5 content to global gambling operators

· Partner-agreement with British Gaming platform Bede Gaming · Distribution of Take5 to global gambling operators · Swift and efficient integration to multiple operators via one single connectionSpiffX, which develops and provides consumer orientated gaming applications for mobile platforms, has signed an agreement with British Bede Gaming for the distribution of the Take5 gaming applications through Bede's content aggregator for global gambling operators, PLAY. When Take5 is integrated in PLAY, SpiffX is able to reach all customers via one single connection. Bede Gaming offers

Peikko’s DELTABEAM® Slim Floor Structure chosen for an office and retail complex in Wrocław, Poland

Peikko Group’s Polish subsidiary Peikko Polska Sp. z o.o. has received a remarkable order for an office and retail complex Business Garden Wrocław II located in Wrocław, Poland. The order comprises 4.9 kilometers of DELTABEAM® Composite Beams and more than 800 pieces of PCs® Corbels for the project’s beam connections. The deliveries for the project will start in January and are estimated to continue until September 2018. The complex is planned to be finished by the end of 2019. Business Garden Wroclaw II is the continuation of Business Park I project. The second phase

Toxicology and Safety Studies are Successfully Completed

Redwood Pharma AB (publ) announces that the RP101 toxicology studies are now successfully completed. The Company can thereby continue the development of RP101 and approach the next goal of starting the clinical Phase II study in patients with chronic dry eye disease.Safety studies are a critical step in the development of a pharmaceutical. Redwood Pharma has now successfully completed these regarding RP101, which is a new candidate drug based on a well-known active substance and IntelliGel® - that will for the first time be used in an ophthalmological treatment, which will be administered

Diös raises financing via SFF

Diös has increased its financing via Svensk Fastighetsfinansiering AB (SFF) through a bond issue of SEK 191 million maturing 2019-09-25.The bond is secured by property mortgages and runs with a fixed coupon of 0.345%. It is an increase of an existing bond, issued at a premium to par, which gives Diös an effective interest rate of 0.30 percent. The bonds will be listed on Nasdaq Stockholm.-Financing through SFF is under favourable conditions and gives us good diversification, says Rolf Larsson, CFO of Diös Fastigheter.More information on SFF available on the website www.

Saab Awarded SANDF Mass Field Feeding System Contract

Defence and security company Saab has been awarded a contract to deliver a Mass Field Feeding Capability to the South African National Defence Force (SANDF).The contract will supply the SANDF with mobile containerised kitchens systems which consists of 24 x 50-man systems and 11 x 200-man systems. “Saab is committed to supporting world class capabilities for the SANDF. This contract represents our efforts in strengthening our partnerships with military veterans and small and medium-sized enterprises - in line with national imperatives in South Africa,” says Trevor Raman, President and

Nordea announces results and early participation levels for consent solicitations in respect of certain of its EMTN and GMTN notes

THE DISTRIBUTION OF THIS ANNOUNCEMENT IN CERTAIN JURISDICTIONS MAY BE RESTRICTED BY LAW, AND PERSONS INTO WHOSE POSSESSION THIS ANNOUNCEMENT COMES ARE REQUESTED TO INFORM THEMSELVES ABOUT, AND TO OBSERVE, ANY SUCH RESTRICTIONS. 20 November 2017 On 7 November 2017, Nordea Bank AB (publ) (the "Issuer") announced invitations to holders of the outstanding notes listed in the tables below (each a "Series" and, together, the "Notes") to consent to (i) certain modifications of the terms and conditions (the "Conditions") of the relevant Series and related documents in connection with the

Stora Enso will bring renewable materials to Seefeld Nordic World Ski Championships 2019

STORA ENSO OYJ PRESS RELEASE 20 November 2017 at 10.00 EET The renewable materials company Stora Enso will be the Presenting Sponsor for FIS Nordic World Ski Championships 2019 in Seefeld, Austria. The sponsorship gives Stora Enso the possibility to contribute to a sustainable sports event and showcase its renewable solutions in various applications.Throughout the event, Stora Enso wants to increase the participants’, viewers’ and visitors’ awareness of the benefits of sustainable products. Stora Enso’s products provide a climate-friendly alternative to many products made from fossil

Nordea announces results of consent solicitations in relation to certain of its US MTN notes

THE DISTRIBUTION OF THIS ANNOUNCEMENT IN CERTAIN JURISDICTIONS MAY BE RESTRICTED BY LAW, AND PERSONS INTO WHOSE POSSESSION THIS ANNOUNCEMENT COMES ARE REQUESTED TO INFORM THEMSELVES ABOUT, AND TO OBSERVE, ANY SUCH RESTRICTIONS.20 November 2017 On 7 November 2017, Nordea Bank AB (publ) (the "Issuer") announced invitations to holders of the outstanding notes listed in the table below (each a "Series" and, together, the "Notes") to consent to (i) certain modifications of the terms and conditions (the "Conditions") of the relevant Series and related documents in connection with the

Studsvik appoints new head of Fuel and Materials Technology business area

Joakim Lundström, aged 39 and holding an M.Sc. in Engineering Physics, has been appointed head of the Fuel and Materials Technology business area. Joakim Lundström is currently and will continue to be President of Studsvik Nuclear, which houses the Fuel and Materials Technology operations and nuclear facilities. He has long experience of the nuclear power industry and has worked in the Studsvik Group since 2002. Joakim Lundström will be a member of Studsvik's Executive Group Management and will take up his post on January 1, 2018. For further information, please contact: Michael

Stefan Månsson resigns from Endomines AB Board

Stefan Månsson has decided to resign from Endomines Board of Directors effective immediately. Stefan Månsson resigns from the Board of his own accord due to personal reasons. Stefan Månsson has been a member of the Board since 2013 and was also a member of the Audit Committee and the Technical Committee. After Stefan Månsson´s resignation the Board continues to operate with four members. According to the Articles of Association the Board of Directors shall consist of not fewer than three and not more than eight members with not more than four deputies. ”The Board would like to

Veidekke ASA: Shares purchased by employees in 2017

7 086 employees of Veidekke have received offers to purchase between 50 and 1 000 Veidekke shares each. The employees could choose between two alternatives: Option A with 30 % discount and cash payment and option B with 20 % discount and partial financing. 2 441 employees made use of the offer and subscribed a total of 1.42 million shares during the subscription period from 10 to 17 November. However, there was an oversubscription of 28 % and a reduction was done. After the reduction, the employees were permitted to purchase between 50 and 740 shares each, and a total of 1.10 million

MMT starts offshore geophysical survey for AQUIND Interconnector

MMT has commenced an offshore geophysical survey for the AQUIND Interconnector project. The works will involve a geophysical survey of the proposed cable corridor between the landfall areas near Portsmouth in England and near Dieppe in France. Image: MMT´s Survey and ROV vessel Franklin MMT will utilise two vessels: M/V Franklin for offshore works and M/V Seabeam for nearshore works. The vessels are equipped with latest state-of-the-art survey technology including multibeam echo sounders, side-scan sonars and sub-bottom profilers. AQUIND, MMT and their representatives

Final outcome of Eniro’s cash issue

This press release may not be announced, published or distributed, in whole or in part, directly or indirectly, in the United States, Canada, Japan, Australia, Hong Kong, New Zealand, Singapore, South Africa or any other country where such publication or distribution would violate applicable laws or rules or would require additional documents to be prepared or registered or require any other actions to be taken, in addition to the requirements under Swedish law. This press release is not a prospectus. For further information, please refer to “Important information” in this press release.The

BONESUPPORT™ SIGNS COMMERCIALIZATION AGREEMENT FOR THE ITALIAN MARKET

Lund, Sweden, 08.00 CET, 20 November 2017 – BONESUPPORT™, an emerging leader in innovative injectable bio-ceramic bone substitute products to treat bone voids caused by trauma, infection, disease or related surgery based on its unique CERAMENT® platform today announces it has signed a second distribution agreement for Italy with Citieffe Srl to strengthen its access to trauma and orthopaedic surgeons in this market. Citieffe is a trauma implant manufacturer based in Bologna. It is part of the Medistream Group, owned by ArchiMed an independent French Healthcare Investment Firm. Citieffe,

Nomination Committee appointed for the Annual General Meeting 2018

The Annual General Meeting of Bactiguard Holding AB (publ) will be held on Wednesday 16 May, 2018 in Botkyrka.In accordance with the instructions for the Nomination Committee in Bactiguard Holding AB (publ), the Nomination Committee shall consist of four members. The chairman of the Board of Directors shall contact the three largest shareholders of the Company, in terms of voting power, pursuant to Euroclear Sweden AB’s print out of the share register on 31 August. Each of the three largest shareholders shall be offered the opportunity to, within reasonable time, appoint a member who,

Interim Report Third Quarter 2017

Third quarter · In our previous second quarter report we noted the results should be considered against a strong comparative in the second quarter of 2016. The third quarter results should now however be considered against a weaker comparative in the third quarter of 2016. · Net sales increased by 6% to SEK 95.6 (90.0) million. Adjusted to fixed exchange rates, net sales increased by 9%. · Adjusted operating profit increased by 7% to SEK 28.8 (26.9) million. · Adjusted profit before tax increased by 24% to SEK 21.8 (17.6) million. · In September 2017, Diamorph AB (publ)

Henrik Borelius has decided to leave his position as CEO after 17 years at Attendo

“During his 17 years at Attendo, Henrik Borelius has led the company through a unique transformation, from a company in crisis to become the leading care company in the Nordics. Under Henrik’s leadership Attendo has grown revenues more than 10 times to become the Nordic market leader with satisfied customers, high quality, satisfied employees and the industry’s best margins. Henrik combines strong analytical and strategic capabilities, business leadership close to the operations and a high level of energy. This has been invaluable in the role of CEO. The board and I would like to thank him

Bonava sells 71 rental apartments in Berlin

Bonava is selling a residential project in Berlin, Germany, to the housing company Gewobag. This is the first project sold to Gewobag and consists of 71 rental apartments and four commercial premises. The sale price totals about SEK 120 million.- The development of qualitative and affordable rental units is an important and growing part of our business. This combined with the substantial demand in the German housing market, where an estimated 400,000 new housing units need to be built each year for the next ten years, creates many opportunities for us, and is in line with our strategy to

There are no items matching the current filter
There are no more items matching the current filter
Back to top